Featured Posts
Study
A Free Market is the Best Medicine
Introduction The pharmaceutical supply market is seeing extraordinarily high levels of innovation and consumer-benefiting evolution. The combination of a competitive market for generic drugs,…
Blog
Congress considers micromanaging PBM finances
With the first reconciliation bill behind it, Congress is now looking to reform other aspects of the health care system. Pharmacy Benefit Manager…
Blog
Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power…
Search Posts
Study
Stifling Medical Device Innovation
The United States has long been the home to cutting-edge innovations in the medical device industry. However, increasingly burdensome regulatory policy is driving pioneering research…
Op-Eds
How To Create Shortages In An Abundant World
An old cold war joke asks a Russian, a Pole, an Israeli, and an American the following man-on-the-street question. “Excuse me, what is your opinion…
Breitbart
Breathless: FDA Bans Asthma Medication
Remember when Barack Obama – with the dignity and off-prompter grace, evincing deep understanding of the issues and the eloquence for which he is fawned…
Washington Times
Questionable Motives Behind Supplement Bill
Washington Times
Medical Magellans
Food and Drug Administration (FDA) rules are supposedly intended to ensure the safety and efficacy of new drugs and medical devices. It is FDA’s technology…
Products
Gregory Conko Discussing Cloning Translating Into Big Business and Safety Issues on CNNfn
CNNfn: Money & Markets (c) 2003 Federal Document Clearing House. All Rights Reserved. Friday, October 31, 2003 Business Cloning Translating Into Big Business and Safety…